Page last updated: 2024-08-21

nicotinamide mononucleotide and Albuminuria

nicotinamide mononucleotide has been researched along with Albuminuria in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Hasegawa, K; Itoh, H; Kanda, T; Kawaguchi, T; Kusahana, E; Muraoka, H; Ono, T; Sakamaki, Y; Tokuyama, H; Wakino, S; Yasuda, I	1
Fujimura, K; Guarente, L; Hasegawa, K; Hayashi, K; Hosoya, K; Itoh, H; Kanda, T; Kaneko, Y; Komatsu, M; Kubota, E; Minakuchi, H; Sakamaki, Y; Simic, P; Tokuyama, H; Wakino, S	1
Futatsugi, K; Hasegawa, K; Hayashi, K; Itoh, H; Kanda, T; Minakuchi, H; Muraoka, H; Naitoh, M; Sakamaki, Y; Shinozuka, K; Tokuyama, H; Umino, H; Urai, H; Wakino, S; Yoshifuji, A	1

Reviews

1 review(s) available for nicotinamide mononucleotide and Albuminuria

Article	Year
Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism. Current hypertension reviews, 2016, Volume: 12, Issue:2 Topics: Albuminuria; Cell Communication; Claudin-1; Diabetic Nephropathies; Epithelial Cells; Kidney Glomerulus; Kidney Tubules, Proximal; Nicotinamide Mononucleotide; Nicotinic Acids; Podocytes; Sirtuin 1	2016

Other Studies

2 other study(ies) available for nicotinamide mononucleotide and Albuminuria

Article	Year
Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy. Journal of the American Society of Nephrology : JASN, 2021, 06-01, Volume: 32, Issue:6 Topics: Albuminuria; Animals; Claudin-1; Cytokines; Diabetic Nephropathies; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Dose-Response Relationship, Drug; Epigenesis, Genetic; Glomerular Mesangium; Glycated Hemoglobin; Histones; Male; Mice; Mice, Knockout; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Podocytes; Sirtuin 1; Survival Rate; Time Factors	2021
Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nature medicine, 2013, Volume: 19, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Animals; Claudin-1; Diabetes Mellitus; Diabetes Mellitus, Experimental; Epigenesis, Genetic; Female; Gene Expression Regulation; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Mice, Transgenic; Middle Aged; Nicotinamide Mononucleotide; Podocytes; Sirtuin 1	2013

Article

Year

Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.

Journal of the American Society of Nephrology : JASN, 2021, 06-01, Volume: 32, Issue:6

Topics: Albuminuria; Animals; Claudin-1; Cytokines; Diabetic Nephropathies; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; Dose-Response Relationship, Drug; Epigenesis, Genetic; Glomerular Mesangium; Glycated Hemoglobin; Histones; Male; Mice; Mice, Knockout; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Nicotinamide-Nucleotide Adenylyltransferase; Podocytes; Sirtuin 1; Survival Rate; Time Factors

2021

Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes.

Nature medicine, 2013, Volume: 19, Issue:11

Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Animals; Claudin-1; Diabetes Mellitus; Diabetes Mellitus, Experimental; Epigenesis, Genetic; Female; Gene Expression Regulation; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Mice, Transgenic; Middle Aged; Nicotinamide Mononucleotide; Podocytes; Sirtuin 1

2013